| mySugr GmbH. (6/30/17). "Press Release: mySugr Joins the Roche family". San Diego, CA. |
2017-06-30 |
| iTeos Therapeutics S.A.. (6/29/17). "Press Release: iTeos Therapeutics Appoints Mohamed Ragab, M.D., as Vice President, Corporate Development". Gosselies. |
2017-06-29 |
| Arbeitskreis der BioRegionen. (6/28/17). "Press Release: Dr. Hinrich Habeck folgt nach sechs Jahren Dr. Klaus Eichenberg in seinem Amt. Der neue Sprecher des AK BioRegio setzt auf Fortführung des Erfolgskurses". Berlin. |
2017-06-28 |
| Evotec AG. (6/28/17). "Press Release: Evotec Expands iPSC Drug Discovery Leadership through Strategic Collaboration with Censo Biotechnologies". Hamburg. |
2017-06-28 |
| Cellnovo. (6/28/17). "Press Release: Cellnovo Signs Expanded Agreement to Build Second Production Line with Flex". Paris. |
2017-06-28 |
| Cellectis S.A.. (6/28/17). "Press Release: Cellectis Appoints Rainer Boehm, M.D. and Hervé Hoppenot to Board of Directors". New York, NY. |
2017-06-28 |
| Indi Molecular. (6/28/17). "Press Release: Indi Molecular Raises $11.5M Series A to Accelerate PCC Platform Development". Culver City, CA. |
2017-06-28 |
| BioGeneration Ventures B.V.. (6/27/17). "Press Release: BioGeneration Ventures Fund III Secures EUR 66m, Exceeding EUR 50m Target". Naarden. |
2017-06-27 |
| Selexis S.A.. (6/27/17). "Press Release: Selexis Announces Commercial License Agreement with Takeda for the Development of Fusion Proteins". Geneva. |
2017-06-27 |
| Miltenyi Biotec GmbH. (6/27/17). "Press Release: Miltenyi Biotec Acquires Sensovation". |
2017-06-27 |
| Oculis ehf.. (6/27/17). "Press Release: Eye-drop for Diabetic Retinopathy – Successful Eurostars grant Application". Reykjavik. |
2017-06-27 |
| Bruker Corporation. (6/26/17). "Press Release: Bruker Announces Novel NMR Phenomics Research Capabilities". Brisbane. |
2017-06-26 |
| CureVac AG. (6/26/17). "Press Release: CureVac Expands GMP Production Capacities for RNA Products". Tübingen. |
2017-06-26 |
| EQT Partners. (6/24/17). "Press Release: EQT VII to Invest in Global »Hidden Champion« and Medical Mobility Technology Market Leader Ottobock". |
2017-06-24 |
| Tecan Group Ltd.. (6/23/17). "Press Release: DiaSorin and Tecan to Collaborate in New Platform Development". Saluggia & Männedorf. |
2017-06-23 |
| Merck KGaA. (6/23/17). "Press Release: Cladribine Tablets Receives Positive CHMP Opinion for Treatment of Relapsing Forms of Multiple Sclerosis". Darmstadt. |
2017-06-23 |
| NMI TT Pharmaservices. (6/22/17). "Press Release: NMI TT Pharmaservices and Charité Awarded Grant for Development of Protein Profiling for Individualization of Tumor Therapy". Berlin. |
2017-06-22 |
| DiaSorin S.p.A.. (6/22/17). "Press Release: DiaSorin and Qiagen Sign Collaboration to Expand Liaison Test Menu througth Adoption of Select Qiagen Assays". Saluggia, Hilden & Germantown, MD. |
2017-06-22 |
| Evotec AG. (6/22/17). "Press Release: »Lab282« Accelerates with Second Round Funding". Hamburg. |
2017-06-22 |
| Thermo Fisher Scientific Inc.. (6/22/17). "Press Release: FDA Approves First Companion Diagnostic Test to Simultaneously Screen for Multiple Non-Small Cell Lung Cancer Therapies". Carlsbad, CA. |
2017-06-22 |
| Waters Corporation. (6/22/17). "Press Release: Waters Corporation Elects Flemming Ornskov to Board of Directors". Milford, MA. |
2017-06-22 |
| Repare Therapeutics Inc.. (6/22/17). "Press Release: Repare Therapeutics Raises US$68 Million Series A. Novel Cancer Company Founded by Versant Ventures". |
2017-06-22 |
| Boehringer Ingelheim. (6/21/17). "Press Release: New Data Reveal High Rates of Stroke History in Asymptomatic Atrial Fibrillation Patients". Ingelheim. |
2017-06-21 |
| Invent Farma Holding Spain S.L.. (6/21/17). "Press Release: Invent Farma / Neuraxpharm Group Announces the Acquisition of FB Health in Italy". Barcelona & Düsseldorf. |
2017-06-21 |
| InflaRx GmbH. (6/21/17). "Press Release: InflaRx Promotes Othmar Zenker, M.D. to Newly Created Position of Chief Medical Officer". Jena. |
2017-06-21 |
| Shimadzu Europe GmbH. (6/21/17). "Press Release: Shimadzu Has Acquired AlsaChim, a Specialist for High-quality Analytical Isotope Labeled Standards". |
2017-06-21 |
| OBN (UK) Ltd.. (6/20/17). "Press Release: OBN (UK) and Eurasanté (FR) Announce the Launch of BioSeed. A New European Equity Investment Event to Support Early-Stage Companies in Life Sciences". Oxford. |
2017-06-20 |
| Merck KGaA. (6/20/17). "Press Release: Merck Ventures Creates New Immuno-Oncology Company iOnctura". Darmstadt. |
2017-06-20 |
| Evotec AG. (6/20/17). "Press Release: Evotec Announces Strategic Investment in Facio Therapies to Support Development of Novel FSHD Therapy". Hamburg. |
2017-06-20 |
| Affiris AG. (6/20/17). "Press Release: Vaccine that Lowers Cholesterol in Mice Offers Hope of Immunising against Cardiovascular Disease". |
2017-06-20 |
| Debiopharm International SA. (6/20/17). "Press Release: Almac Discovery and Debiopharm International SA Announce a Licensing Agreement for the Development of a Novel Wee-1 Inhibitor". Craigavon & Lausanne. |
2017-06-20 |
| PerkinElmer, Inc.. (6/19/17). "Press Release: PerkinElmer to Acquire Euroimmun for Approximately $1.3 Billion". Waltham, MA. |
2017-06-19 |
| CRISPR Therapeutics AG. (6/19/17). "Press Release: CRISPR Therapeutics Announces Patent for CRISPR/Cas Genome Editing in China". Basel. |
2017-06-19 |
| Gamida Cell Ltd.. (6/19/17). "Press Release: Gamida Cell Announces $40 Million Private Financing". Jerusalem. |
2017-06-19 |
| Intellia Therapeutics, Inc.. (6/19/17). "Press Release: Intellia Therapeutics Announces Patent for CRISPR/Cas Genome Editing in China". Cambridge, MA. |
2017-06-19 |
| TxCell S.A.. (6/19/17). "Press Release: TxCell Appoints Lentigen Technology, Inc. to Manufacture the Lentiviral Vector for Its First CAR-Treg Program in Transplant Rejection". Valbonne. |
2017-06-19 |
| Wilex AG. (6/19/17). "Press Release: Wilex Subsidiary Heidelberg Pharma Signs Exclusive Multi-target Research Agreement with Takeda for the Development of Antibody Targeted Amanitin Conjugates". Munich. |
2017-06-19 |
| Novartis AG. (6/19/17). "Press Release: Sandoz Receives Approval in Europe for Rixathon (Biosimilar Rituximab) to Treat Blood Cancers and Immunological Diseases". Holzkirchen. |
2017-06-19 |
| G1 Therapeutics, Inc.. (6/17/14). "Press Release: G1 Therapeutics Completes Leadership Team with Appointment of Raj Malik, MD, Chief Medical Officer and Greg Mossinghoff, Chief Business Officer". Research Triangle Park, NC. |
2017-06-17 |
| Idorsia Ltd.. (6/16/17). "Press Release: Idorsia – Reaching Out for More. Idorsia Commences Trading on SIX Swiss Exchange (Ticker: IDIA)". Allschwil. |
2017-06-16 |
| Actelion Ltd.. (6/16/17). "Press Release: Johnson & Johnson Completes Acquisition of Actelion". Allschwil. |
2017-06-16 |
| Oncotec Pharma Produktion GmbH. (6/16/17). "Press Release: Oncotec Celebrates 20 Years of Successful Company History at the Dessau Site". Dessau. |
2017-06-16 |
| Helsinn Healthcare S.A.. (6/16/17). "Press Release: Helsinn Investment Fund Leads the Financial Round in GreenBone". Lugano. |
2017-06-16 |
| Medicxi Ventures. (6/15/17). "Press Release: Medicxi Launches First $300m Late-stage Life Sciences Fund Medicxi Growth 1 (MG1), Backed by Novartis and Verily". London & Geneva. |
2017-06-15 |
| ProBioGen AG. (6/15/17). "Press Release: ProBioGen Grants a License for Human Lymph Node Technology to TissUse for Multi-Organ-Chip Applications". Berlin. |
2017-06-15 |
| Merck KGaA. (6/15/17). "Press Release: Merck Expands Distribution Agreement with Public Health England". Darmstadt. |
2017-06-15 |
| Biophytis S.A.. (6/15/17). "Press Release: Biophytis Selects SGS Life Science Services to Conduct MACA-PK, Clinical Study of Macuneos in Dry AMD". Paris. |
2017-06-15 |
| Human Longevity, Inc.. (6/15/17). "Press Release: Human Longevity, Inc. Announces Agreement with Merck KGaA, Darmstadt, Germany to Engage in Cancer Biomarker Discovery in Advanced Melanoma". San Diego, CA. |
2017-06-15 |
| Cellestia Biotech AG. (6/15/17). "Press Release: Cellestia Biotech AG Extends Management Team and Scientific Advisory Board". Basel. |
2017-06-15 |
| Bayer AG. (6/14/17). "Press Release: Bayer and the Shanghai Institutes of Biological Sciences Team Up to Enhance Crop Yields". Monheim. |
2017-06-14 |
| Merck KGaA. (6/14/17). "Press Release: Merck Awarded its First CRISPR Patent by Australian Patent Office". Darmstadt. |
2017-06-14 |
| Actelion Ltd.. (6/14/17). "Press Release: Actelion Announces Changes to Its Executive Team upon Completion of the Transaction with Johnson & Johnson". Allschwil. |
2017-06-14 |
| Selexis S.A.. (6/14/17). "Press Release: JSR Life Sciences Agrees to Acquire Pioneering Cell Line Developer Selexis SA and Integrate Selexis with KBI Biopharma, Inc.". Tokyo & Geneva. |
2017-06-14 |
| Evotec AG. (6/14/17). "Press Release: Evotec Joins NURTuRE Consortium to Mine Unique Kidney Disease Patient Biobank". Hamburg. |
2017-06-14 |
| CRISPR Therapeutics AG. (6/14/17). "Press Release: CRISPR Therapeutics to Present at the JMP Securities Life Sciences Conference". Basel & Cambridge, MA. |
2017-06-14 |
| Mundipharma International Ltd.. (6/14/17). "Press Release: New Data Show Truxima (CT-P10) to Have Comparable Efficacy and Tolerability in Advanced Follicular Lymphoma to Reference i.v. Rituximab". Cambridge. |
2017-06-14 |
| Basilea Pharmaceutica Ltd.. (6/14/17). "Press Release: Basilea Announces License Agreement with Pfizer for Antifungal Cresemba (isavuconazole) for Europe, Russia, Turkey and Israel". Basel. |
2017-06-14 |
| Centogene AG. (6/13/17). "Press Release: Centogene Raises a EUR 25 Million Series A Financing to Fuel Innovation and to Accelerate Growth into Personalized Medicine". Rostock & Berlin. |
2017-06-13 |
| Ablynx N.V.. (6/13/17). "Press Release: Ablynx Appoints Markus Ewert as Chief Business Officer". Ghent. |
2017-06-13 |
| CureVac AG. (6/13/17). "Press Release: CureVac Extends Global Intellectual Property Estate for Prophylactic mRNA Vaccines". Tübingen. |
2017-06-13 |
| Numab Therapeutics AG. (6/13/17). "Press Release: Numab and Kaken Pharmaceutical Co., Ltd. Enter into a Collaboration and Option Agreement". Pfäffikon. |
2017-06-13 |
| Boehringer Ingelheim. (6/12/17). "Press Release: Empagliflozin (Jardiance) to Be Studied in Chronic Kidney Disease". Ingelheim & Indianapolis, IN. |
2017-06-12 |
| Thermo Fisher Scientific Inc.. (6/12/17). "Press Release: Thermo Fisher Scientific Ushers in New Era of Clinical Mass Spectrometry with World's First Fully Integrated Laboratory Analyzer". Athens. |
2017-06-12 |
| Thermo Fisher Scientific Inc.. (6/12/17). "Press Release: New Immunoassay for Detection of Buprenorphine and Three Major Metabolites". Athens. |
2017-06-12 |
| Selexis S.A.. (6/12/17). "Press Release: Selexis SA and TeneoBio, Inc. Team Up to Advance the Development of UniAbs Targeting Cancer". Geneva & Menlo Park, CA. |
2017-06-12 |
| Helsinn Healthcare S.A.. (6/12/17). "Press Release: Zealand to Regain Control of Elsiglutide. Helsinn Returns Elsiglutide to Zealand". Lugano & Copenhagen. |
2017-06-12 |
| Bruker Corporation. (6/12/17). "Press Release: Bruker Launches verTera Terahertz Extension for Vertex 80v. Innovative Technology Accesses THz Range Without Cryogens". Ettlingen. |
2017-06-12 |
| Evolva Holding S.A.. (6/12/17). "Press Release: Scott Fabro to Join Evolva as Chief Commercial Officer". |
2017-06-12 |
| Probiodrug AG. (6/11/17). "Press Release: Probiodrug Announces Encouraging Results of the Phase 2a SAPHIR Study". Halle (Saale). |
2017-06-11 |
| Leman Instruments SAS. (6/9/17). "Press Release: Leman Instruments Introduces New Family of High Purity Oxygen Generators. OXYSTATION 20 LC and OXYSTATION 40LC Instruments Now Available". Archamps. |
2017-06-09 |
| Alacrita LLP. (6/9/17). "Press Release: Alacrita Appoints Anna Casse as 4th Managing Partner To Strengthen Commercial Advisory Services and Build a European Launch Platform". |
2017-06-09 |
| Eli Lilly and Company. (6/8/17). "Press Release: Lilly Announces Strategic Collaboration with KeyBioscience AG". Stans & Indianapolis, IN. |
2017-06-08 |
| Boehringer Ingelheim. (6/8/17). "Press Release: Boehringer Ingelheim Builds Digital Lab »BI X« with Focus on Innovative Digital Solutions in Healthcare". Ingelheim. |
2017-06-08 |
| Qiagen N.V.. (6/8/17). "Press Release: Qiagen’s QuantiFERON-TB Gold Plus Gains U.S. FDA Approval". Germantown, MD & Hilden. |
2017-06-08 |
| NewLink Genetics Corporation. (6/8/17). "Press Release: NewLink Genetics to Regain Rights to GDC-0919". Ames, IA. |
2017-06-08 |
| Bayer AG. (6/8/17). "Press Release: Bayer and KWS Grant First License for Herbicide-tolerant Sugarbeet to SESVanderHave". Leverkusen. |
2017-06-08 |
| Omeicos Therapeutics GmbH. (6/7/17). "Press Release: Omeicos Secures Continued BMBF Support with New €1.7m Research Grant to Advance its Novel Approach to Treat Cardiovascular Diseases". Berlin. |
2017-06-07 |
| CRISPR Therapeutics AG. (6/7/17). "Press Release: CRISPR Therapeutics Appoints James R. Kasinger as General Counsel". Basel. |
2017-06-07 |
| SepSolve Analytical Ltd.. (6/7/17). "Press Release: SepSolve Analytical Grows from Consultancy to »Complete Solution Provider«". |
2017-06-07 |
| SepSolve Analytical Ltd.. (6/7/17). "Press Release: SepSolve Analytical Opens the Door to Routine GC×GC Analyses". |
2017-06-07 |
| Pepperprint GmbH. (6/7/17). "Press Release: Pepperprint and Progen Develop Novel Test for Early Diagnosis of Rheumatoid Arthritis". Heidelberg. |
2017-06-07 |
| Grünenthal GmbH. (6/7/17). "Press Release: Grünenthal Enters Agreement with AstraZeneca to Acquire Global Rights to Migraine Treatment Zomig (Zolmitriptan)". Aachen: Athenäum. |
2017-06-07 |
| Themis Bioscience GmbH. (6/6/17). "Press Release: NIH and Themis Bioscience Announce the Initiation of a Clinical Trial of a Chikungunya Vaccine". Vienna. |
2017-06-06 |
| CRISPR Therapeutics AG. (6/6/17). "Press Release: CRISPR Therapeutics and MaSTherCell SA Sign Service Agreement for the Development and Manufacturing of Allogeneic Cell Therapies". Basel, Cambridge, MA & Gosselies. |
2017-06-06 |
| Qiagen N.V.. (6/6/17). "Press Release: Qiagen Receives U.S. FDA Approval for Cytomegalovirus (CMV) Testing on Automated QIAsymphony Platform". Germantown, MD & Hilden. |
2017-06-06 |
| Sygnis AG. (6/6/17). "Press Release: Sygnis AG Announces Management and Supervisory Board Changes. Dr. Heikki Lanckriet Sole CEO". Madrid & Heidelberg. |
2017-06-06 |
| Bruker Corporation. (6/5/17). "Press Release: Bruker Introduces Novel Mass Spectrometry Solutions for MALDI Imaging, Metabolomics, Proteoform Profiling and Toxicology at ASMS 2017". Indianapolis, IN. |
2017-06-05 |
| Roche. (6/5/17). "Press Release: APHINITY Study Shows Roche’s Perjeta-based Regimen Reduced the Risk of Invasive Cancer Returning Compared to Herceptin and Chemotherapy in HER2-positive Early Breast Cancer". Basel. |
2017-06-05 |
| Roche. (6/5/17). "Press Release: Phase III Study Showed Roche’s Alecensa (alectinib) Reduced the Risk of Disease Progression or Death by more than Half versus Crizotinib as First-line Treatment in a Specific Type of Lung Cancer". Basel. |
2017-06-05 |
| Boehringer Ingelheim. (6/5/17). "Press Release: Encouraging Phase II Survival Data for Nintedanib in Malignant Pleural Mesothelioma Presented at ASCO 2017". Ingelheim. |
2017-06-05 |
| Thermo Fisher Scientific Inc.. (6/5/17). "Press Release: Thermo Fisher Scientific and Biognosys Announce Co-Marketing Agreement to Create Industry-leading Data-Independent Acquisition Workflows". Indianapolis, IN. |
2017-06-05 |
| Thermo Fisher Scientific Inc.. (6/5/17). "Press Release: Thermo Fisher Scientific and Biocrates Life Sciences Launch Industry’s First Kit for Comprehensive Metabolome Analysis". Indianapolis, IN. |
2017-06-05 |
| F-Star Biotechnology Ltd.. (6/4/17). "Press Release: F-star Expands Its Relationship with Merck through a New Strategic Collaboration to Develop Bispecific Antibodies in Immuno-Oncology". Cambridge. |
2017-06-04 |
| Bristol-Myers Squibb Company. (6/3/17). "Press Release: Bristol-Myers Squibb and Qiagen Sign Agreement for Use of NGS Technology to Develop Gene Expression Profiles for Immuno-Oncology Therapies". New York, NY & Hilden. |
2017-06-03 |
| Qiagen N.V.. (6/3/17). "Press Release: Qiagen Expands Biomarker Content Portfolio to Support Greater Use of Molecular Diagnostics for Immuno-oncology Therapies". Hilden & Germantown, MD. |
2017-06-03 |
| Roche. (6/3/17). "Press Release: Roche Presents New Data for Tecentriq (atezolizumab) and Updates from Across Its Cancer Immunotherapy Development Programme at ASCO 2017". Basel. |
2017-06-03 |
| Forge Therapeutics, Inc.. (6/3/17). "Press Release: Forge Therapeutics and Evotec Present First Efficacy Data for LpxC Inhibitor in UTI Model at ASM Microbe 2017". San Diego, CA. |
2017-06-03 |
| GATC Biotech AG. (6/2/17). "Press Release: GATC to Be Part of Eurofins Group". Constance. |
2017-06-02 |
| Eurofins Scientific. (6/2/17). "Press Release: Eurofins Strengthens Its Genomics and Genetic Testing Footprint with the Acquisition of GATC in Germany". |
2017-06-02 |
| Basilea Pharmaceutica Ltd.. (6/2/17). "Press Release: Basilea Names New Member of Its Extended Management Committee". Basel. |
2017-06-02 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 32 33 34 ... 44 45 46 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
